Respiratory Disease Models | Charles River

Respiratory Models 

By combining long-standing expertise with new research solutions, Charles River advances drug discovery for treatments of respiratory diseases. Our recently validated rodent models provide rapid, cost-effective methods for evaluating the potential efficacy of novel anti-inflammatory agents targeting COPD or asthma conditions.

 

To learn more about  our wide range of capabilities to support your respiratory research, click here.

Related Information

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jan 31 - Discovery PK Now Offered at Charle...
May 13 - High-Throughput Screening for CNS ...
May 28-Jun 01 - Kobe, Japan - Joint Meeting of the International Bone and Mineral Socie...
May 23-May 23 - East Lansing, Michigan, USA - The Ins and Outs of Transgenic Colongy Ma...

Charles River Laboratories, Inc.